Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 23, 2022 - Issue 3-4
Submit an article Journal homepage
1,988
Views
0
CrossRef citations to date
0
Altmetric
Clinical

Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of reldesemtiv in ALS: post hoc analyses of a randomized, double-blind, placebo-controlled clinical trial

Stacy A. Rudnicki1 Cytokinetics, Incorporated, South San Francisco, CA, USACorrespondence[email protected]
View further author information
,
Jinsy A. Andrews2 The Neurological Institute, Columbia University, New York, NY, USAView further author information
,
Angela Genge3 Montreal Neurological Institute, Montreal, QC, CanadaView further author information
,
Carlayne Jackson4 Departments of Neurology and Otolaryngology, University of Texas Health Science Center, San Antonio, TX, USAView further author information
,
Noah Lechtzin5 Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USAView further author information
,
Timothy M. Miller6 Department of Neurology, Washington University School of Medicine, St. Louis, MO, USAView further author information
,
Bettina M. Cockroft1 Cytokinetics, Incorporated, South San Francisco, CA, USAView further author information
,
Fady I. Malik1 Cytokinetics, Incorporated, South San Francisco, CA, USAView further author information
,
Lisa Meng1 Cytokinetics, Incorporated, South San Francisco, CA, USAView further author information
,
Jenny Wei1 Cytokinetics, Incorporated, South San Francisco, CA, USAView further author information
,
Andrew A. Wolff1 Cytokinetics, Incorporated, South San Francisco, CA, USAView further author information
,
Jeremy M. Shefner7 Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, USAView further author information
& ON BEHALF OF THE FORTITUDE-ALS STUDY GROUP show all
Pages 263-270 | Received 14 Jan 2021, Accepted 14 Jun 2021, Published online: 05 Jul 2021

References

  • Gladman M, Zinman L. The economic impact of amyotrophic lateral sclerosis: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15:439–50.
  • Bromberg MB, Brownell AA, Forshew DA, Swenson M. A timeline for predicting durable medical equipment needs and interventions for amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler. 2010;11:110–15.
  • Funke A, Spittel S, Grehl T, Grosskreutz J, Kettemann D, Petri S, et al. Provision of assistive technology devices among people with ALS in Germany: a platform-case management approach. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:342–50.
  • Andrews JA, Miller TM, Vijayakumar V, Stoltz R, James JK, Meng L, et al. CK-2127107 amplifies skeletal muscle response to nerve activation in humans. Muscle Nerve. 2018;57:729–34.
  • Hansen R, Saikali KG, Chou W, Russell AJ, Chen MM, Vijayakumar V, et al. Tirasemtiv amplifies skeletal muscle response to nerve activation in humans. Muscle Nerve. 2014;50:925–31.
  • Shefner JM, Andrews JA, Genge A, Jackson C, Lechtzin N, Miller TM, et al. A phase 2, double-blind, randomized, dose-ranging trial of reldesemtiv in patients with ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:287–99.
  • Creemers H, Beelen A, Grupstra H, Nollet F, van den Berg LH. The provision of assistive devices and home adaptations to patients with ALS in the Netherlands: patients' perspectives. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:420–25.
  • Hogden A, Foley G, Henderson RD, James N, Aoun SM. Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. J Multidiscip Healthc. 2017;10:205–15.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.